ARS Pharmaceuticals to Participate in the SVB Securities

ARS Pharmaceuticals to Participate in the SVB Securities

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk......

menu
menu